

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| HC9 Ventures II | October 2025 | $85M | $31M | 58 |
| HC9 Ventures I | 2022 | $83M | $83M | 139 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Charles Falcone | Slowing | Healthcare services | 1 | 1 |
| Richard Lungen | Slowing | Digital health | 1 | 1 |
| Jonathan GordonNot on the current fund | Quiet | Biotech & pharma, Climate & energy, Digital health | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Categories of HC9 Ventures’s own portfolio companies, based on 7 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of HC9 Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Montage Ventures | 1 | Post Acute Recovery |
| Mudita Venture Partners | 1 | MARXENT LABS |
| Playground Global | 1 | Universal Hydrogen |
A shared board seat: a company where filings name a HC9 Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.